Assura Plc (LON:AGR – Get Rating) has been assigned a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is GBX 79.83 ($1.00).
AGR has been the subject of a number of recent research reports. Peel Hunt restated an “add” rating and set a GBX 85 ($1.07) price target on shares of Assura in a research note on Tuesday, May 24th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a GBX 79 ($0.99) price objective on shares of Assura in a research note on Wednesday. Berenberg Bank reiterated a “hold” rating and set a GBX 80 ($1.01) price objective on shares of Assura in a research note on Wednesday, April 13th. Barclays reiterated an “overweight” rating and set a GBX 80 ($1.01) price objective on shares of Assura in a research note on Monday, May 23rd. Finally, Shore Capital reiterated a “buy” rating on shares of Assura in a research note on Tuesday, May 24th.
Shares of LON:AGR opened at GBX 71.05 ($0.89) on Thursday. Assura has a fifty-two week low of GBX 59.28 ($0.75) and a fifty-two week high of GBX 80.60 ($1.01). The business has a 50-day simple moving average of GBX 67.18 and a two-hundred day simple moving average of GBX 66.93. The company has a debt-to-equity ratio of 69.84, a quick ratio of 3.62 and a current ratio of 4.64. The firm has a market cap of £2.10 billion and a price-to-earnings ratio of 12.69.
Assura Company Profile (Get Rating)
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities.
See Also
- These Are the Three (3) Most Upgraded Stocks For Q2
- MarketBeat: Week in Review 5/23 – 5/27
- Short Sellers Provide Entry Into Hibbet, Inc At Rock Bottom Prices
- Affirm Stock Has Affirmed a Bottom
- Airbnb: Bold Competitive Threats & A New World of Travel
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.